Executive Director, Market Access

Allogene Therapeutics • South San Francisco, CA

2d • $280,000 - $320,000

About The Position

Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease. Led by a management team with significant experience in cell therapy, Allogene is developing a pipeline of “off-the-shelf” CAR T cell product candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients. Allogene Therapeutics is seeking a highly motivated Executive Director, Market Access who will define and lead Allogene’s global market access strategy to support the successful launch and commercialization of its allogeneic CAR T therapies. This leader will be responsible for pricing strategy, payer engagement, reimbursement, patient support services, and distribution strategy to ensure optimal patient access and sustainable product value. Given the unique complexities of CAR T therapy, this role will play a critical part in addressing site-of-care dynamics, center-of-excellence (COE) networks, single case agreements, and innovative payment models to enable broad access across both academic and community oncology settings. As a key member of the Commercial organization, this role will partner closely with Corporate Affairs, Business Development, Medical Affairs, HEOR, Clinical Development, and Regulatory to shape evidence generation, value propositions, and access strategies that support payer adoption and reimbursement. This position will play a critical role in preparing Allogene for launch and building the market access infrastructure required to support a growing commercial organization.

Requirements

• Bachelor’s, Master’s or Pharm.D. degree in Life Sciences or related field (or relevant experience)
• 15+ years of experience in market access, pricing, reimbursement, or related roles within biotech or pharmaceutical industry, including leadership experience
• Demonstrated experience developing and executing market access strategy for oncology or specialty therapies, with direct experience in CAR T or cell therapy strongly preferred
• Deep understanding of CAR T reimbursement dynamics, including single case agreements, site-of-care considerations, and COE network requirements
• Experience working across both academic medical centers and community oncology settings
• Strong understanding of innovative payment models and access considerations for high-cost, one-time therapies
• Knowledge of oncology clinical data and health economics to support value-based discussions
• Proven ability to lead cross-functional initiatives and influence senior stakeholders
• Strong negotiation, communication, and analytical skills
• Ability to operate effectively in a fast-paced, high-growth biotech environment
• Strong financial management and business acumen
• Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines
• Strong interpersonal skills including verbal and written communication are essential in this collaborative work environment
• Candidates must be authorized to work in the U.S.

Responsibilities

• Develop and execute a comprehensive market access strategy, including pricing, reimbursement, and payer engagement, to support launch and lifecycle management of allogeneic CAR T therapies
• Lead cross-functional development of payer value propositions, access strategies, and evidence plans aligned with clinical and commercial objectives
• Establish and maintain relationships with national and regional payers, including commercial insurers, Medicare Advantage, Medicaid, and employer groups, to secure favorable coverage and reimbursement
• Lead negotiation of coverage policies, reimbursement terms, single case agreements, and contract strategies specific to cell therapy delivery
• Design and implement access strategies that address CAR T–specific site-of-care requirements, including academic centers, community oncology practices, and evolving outpatient delivery models
• Monitor and influence payer and government policy, including CMS and state Medicaid developments, to address access barriers and support patient access
• Develop and implement innovative payment models and contracting approaches to support high-cost, one-time therapies
• Build and lead a field reimbursement organization to support providers navigating complex CAR T access pathways
• Design and implement patient support services to facilitate access, including benefits verification, reimbursement support, and care coordination
• Partner with Supply Chain and Commercial teams to develop distribution and channel strategies aligned with cell therapy logistics and treatment center capabilities
• Track payer coverage, reimbursement trends, COE network requirements, and competitive dynamics to inform strategy
• Provide strategic input into business development and financial planning related to pricing, access, and reimbursement
• Ensure all market access activities comply with relevant regulations and industry standards
• Other duties as assigned

Benefits

• We offer a chance to work with talented people in a collaborative environment and provide a top-notch compensation and benefits package, which includes an annual performance bonus, equity, health insurance, generous time off (including 2 annual holiday company-wide shutdowns) and much more.

What This Job Offers

• Job Type: Full-time
• Career Level: Executive
• Number of Employees: 101-250 employees